Scoping review of supportive care intervention schemes for patients with liver cancer
10.3760/cma.j.cn115682-20231010-01439
- VernacularTitle:肝癌患者支持性照护干预方案的范围综述
- Author:
Lanfang ZHUO
1
;
Chunfeng CAI
;
Xinyi ZHENG
Author Information
1. 武汉大学护理学院，武汉 430000
- Keywords:
Review;
Liver neoplasms;
Supportive care
- From:
Chinese Journal of Modern Nursing
2024;30(24):3341-3347
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize the research status of supportive care intervention schemes for patients with liver cancer, analyze relevant studies and identify the forms, contents, outcome indicators and effects of interventions, in order to provide references for medical staff to carry out relevant research.Methods:The scoping review method was used to search relevant articles in WanFang data, VIP, China National Knowledge Infrastructure, Web of Science, PubMed, Embase, Scopus, CINAHL and Cochrane Library. The search period was from the establishment of the databases to May 2, 2023, and the included articles was analyzed.Results:A total of 14 articles were included. The intervention scheme included information and care skills guidance, palliative care support, psychological support, multidisciplinary team support, family rehabilitation exercise guidance, and stress management. Intervention forms included online, offline and mixed intervention. The intervention duration was usually 3 or 6 months. The intervention frequency was usually 1~5 times a week, with each session lasting 20~60 minutes. The intervention scheme could improve the quality of life of liver cancer patients to a certain extent, alleviate anxiety and depression.Conclusions:At present, supportive care interventions are led by nurses and have the characteristics of comprehensiveness, personalization and unclear intervention effects. In the future, it is necessary to further optimize the content and strategy of intervention, and formulate scientific, applicable and standardized supportive care intervention schemes according to the disease and physical function status of liver cancer patients.
